Systemic sclerosis a significant patient and health resource economic burden

2021 ◽  
Vol 893 (1) ◽  
pp. 29-29
Keyword(s):  
Systemic Sclerosis ◽  
Economic Burden ◽  
Health Resource

The economic burden of systemic sclerosis—A systematic review

2021 ◽  
Author(s):  
Yongcong Chen ◽  
Lin Wu ◽  
Jose J. Hernández‐Muñoz ◽  
Michael J. Miller ◽  
Melinda Pope ◽  
...  
Keyword(s):  
Systematic Review ◽  
Systemic Sclerosis ◽  
Economic Burden

scholarly journals The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Kathleen Morrisroe ◽  
Wendy Stevens ◽  
Joanne Sahhar ◽  
Gene-Siew Ngian ◽  
Nava Ferdowsi ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Economic Burden ◽  
Pulmonary Arterial

scholarly journals Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life

Rheumatology ◽  
2017 ◽  
Vol 57 (1) ◽  
pp. 73-83 ◽  
Author(s):  
Kathleen Morrisroe ◽  
Vijaya Sudararajan ◽  
Wendy Stevens ◽  
Joanne Sahhar ◽  
Jane Zochling ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Systemic Sclerosis ◽  
Economic Burden ◽  
Work Productivity ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey

Rheumatology ◽  
2010 ◽  
Vol 49 (5) ◽  
pp. 982-989 ◽  
Author(s):  
C. Nguyen ◽  
S. Poiraudeau ◽  
C. Mestre-Stanislas ◽  
F. Rannou ◽  
A. Berezne ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Economic Burden ◽  
Employment Status ◽  
Cross Sectional Survey ◽  
Cross Sectional

scholarly journals Medication Usage Pattern, Health Resource Utilization and Economic Burden for Patients with Mdd in Beijing, China

2014 ◽  
Vol 17 (7) ◽  
pp. A457
Author(s):  
H. Zhang ◽  
L. Yue ◽  
Y. Chen ◽  
H. Ding ◽  
K. Zhao ◽  
...  
Keyword(s):  
Resource Utilization ◽  
Economic Burden ◽  
Usage Pattern ◽  
Health Resource ◽  
Medication Usage ◽  
Health Resource Utilization ◽  
Beijing China

scholarly journals Gender disparities in health resource utilization in patients with relapsing–remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 patients

2020 ◽  
Vol 13 ◽  
pp. 175628642096027
Author(s):  
Dirk Schriefer ◽  
Nils-Henning Ness ◽  
Rocco Haase ◽  
Tjalf Ziemssen
Keyword(s):  
Multiple Sclerosis ◽  
Gender Differences ◽  
Resource Utilization ◽  
Resource Use ◽  
Economic Burden ◽  
Indirect Costs ◽  
Skewed Distribution ◽  
Cost Driver ◽  
Health Resource ◽  
Men And Women

Background: For the case of multiple sclerosis, research on gender differences from a health economics perspective has not received much attention. However, cost-of-illness analyses can provide valuable information about the diverse impact of the disease and thus help decision-makers to allocate scarce resources. The aim of this study was to describe healthcare resource use and associated societal costs from a gender perspective. In particular, we aimed to identify how resource utilization potentially differs in certain cost components between men and women. Methods: Clinical and economic data were extracted from two prospective, multicentre, non-interventional, observational studies in Germany. Information on health resource use was obtained from all patients on a quarterly basis using a validated questionnaire. Cost analyses were conducted from the societal perspective including all direct (healthcare-related) and indirect (work-related) costs, regardless of who bears them. Gender-related differences were analysed by a multivariable generalized linear model with a negative binomial distribution and log link function due to the right-skewed distribution pattern of cost data. In addition, costs for men and women were descriptively analysed within subgroups of two-year disease activity. Results: In total, 2095 patients (women-to-men ratio of 2.7:1) presented a mean age of 41.85 years and a median Expanded Disability Status Scale of 2 (interquartile range 1–3.5) ( p > 0.30 for gender-related differences). Women and men did not statistically differ in total quarterly costs (€2329 ± €2570 versus €2361 ± €2612). For both, costs were higher with advancing disease severity and indirect costs were the main societal cost driver. Regarding healthcare-related resources, women incurred higher costs for ambulant consultations [incidence rate ratio (IRR) 1.16, confidence interval (CI) 1.04–1.31], complementary medicine (IRR 2.41, CI 1.14–5.06), medical consumables (IRR 2.53, CI 1.69–3.79) and informal care (IRR 2.79, CI 1.56–5.01). Among indirect costs, we found higher costs for men for presenteeism (IRR 0.62; CI 0.53–0.72) and higher costs for women for disability pension (IRR 1.62; CI 1.23–2.13). Conclusions: Multiple sclerosis poses a significant economic burden on patients, families and society. While the total economic burden did not differ between male and female patients, we found gender differences in specific cost items that are similar to those in the wider non-MS population.

Sign in / Sign up

Export Citation Format

Share Document